Chris Earwood

A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial

Andrew H. Ko, Patrick Murphy, James D. Peyton et al. · The Oncologist · 2017 · 49 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors

Johanna C. Bendell, Todd M. Bauer, Ruth E. Lamar et al. · Cancer Investigation · 2016 · 43 citations

Medicine, Oncology, Pharmacology +6

A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer

Johanna C. Bendell, Suzanne F. Jones, Lowell L. Hart et al. · Investigational New Drugs · 2014 · 42 citations

Medicine, Oncology, Pharmacology +16

A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors

Johanna C. Bendell, Suzanne F. Jones, Lowell L. Hart et al. · Cancer Investigation · 2015 · 20 citations

Medicine, Oncology, Pharmacology +13

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Johanna C. Bendell, Ahmed Zakari, James D. Peyton et al. · The Oncologist · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17